The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma (Q47710513)
Jump to navigation
Jump to search
scientific article published on 8 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma |
scientific article published on 8 May 2008 |
Statements
1 reference
The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma (English)
1 reference
Eleanor J Cheadle
1 reference
David E Gilham
1 reference
Robert E Hawkins
1 reference
8 May 2008
1 reference
142
1 reference
1
1 reference
65-68
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference